Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
BIOCQ Stock — Biocept Inc.
Biocept Inc. (BIOCQ)
Updated November 11, 2026.
BIOCQ is a stock. Total return is 100.0% over the past 1.2 years, 80.9 points ahead of SPY at 19.1%.
Biocept, Inc. was a molecular oncology diagnostics company that developed blood and cerebrospinal fluid tests to identify rare tumor cells and detect cancer-related genetic changes, helping physicians select targeted therapies and monitor treatment resistance across solid tumors and brain cancers. The company does not currently distribute to shareholders. Biocept filed for liquidation under Chapter 7 bankruptcy in October 2023.
BIOCQ dividend yield and income
Price as of 2026-11-11.
The payment date is 09/08/2020.
BIOCQ performance versus SPY
Total return is 100.0% over the past 1.2 years, 80.9 points ahead of SPY at 19.1%. Its deepest 1-year drawdown was 95.0%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | 0.0% | — |
| 3M | 100.0% | — |
| 6M | 100.0% | — |
| YTD | 100.0% | — |
| 1Y | 100.0% | — |
| Since 2025-08-27 (first price on file) · 1.2 years | 100.0% | 77.60% |
BIOCQ key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 02/05/2014
- Distribution frequency
- None
- Last close
- $0.0002 (stale; as of 2026-11-11)
- Market cap
- $525
- Average volume
- 225
- Payment date
- 09/08/2020
- Payout ratio
- 0.0%
- EPS
- -$167.55
How Dividend Vision calculates returns
Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
BIOCQ risks and drawbacks
The deepest 1-year drawdown on record here is 95.0%.
Who may consider BIOCQ — and who may not
It is a weaker fit for investors who need monthly cash flow (BIOCQ does not currently distribute). This is educational context, not a recommendation to buy or sell.
More on BIOCQ
Frequently asked questions
Does BIOCQ pay monthly?
No. BIOCQ does not currently distribute.
When does BIOCQ pay a dividend?
BIOCQ does not currently distribute. The payment date is 09/08/2020.
How has BIOCQ performed?
Total return is 100.0% over the past 1.2 years, 80.9 points ahead of SPY at 19.1%. Its deepest 1-year drawdown was 95.0%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.